SanaClis is opening branches all over world
- Vladimír Dohnal

- Mar 11, 2024
- 1 min read
SanaClis (Natália Feťkovská, Alexander Feťkovský and Juraj Fecanin) provides services for large pharmaceutical companies and small biotech firms in drug clinical trials as well as drug R&D. In 2022, it reported a net profit of €2.6m on revenues of €17.2m. It employs 80 in Slovakia and has 14 offices worldwide. Last year, it opened a €9.2m drug distribution center in the US, as well as a branch in Mexico, and plans to open offices in Belgium and Scandinavia in the near future.


Comments